CRNO B — Cereno Scientific AB Income Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapNeutral
- SEK76.32m
- SEK32.10m
Annual income statement for Cereno Scientific AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 6.79 | 10.9 | 8.22 | 44.8 | 57.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9.69 | 13.1 | 15.7 | 15 | 27.5 |
| Operating Profit | -9.69 | -13.1 | -15.7 | -15 | -27.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -11.8 | -15.3 | -16 | -16.3 | -27.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.8 | -15.3 | -16 | -16.3 | -27.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.8 | -15.3 | -16 | -16.3 | -27.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.8 | -15.3 | -16 | -16.3 | -27.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.808 | -0.38 | -0.223 | -0.154 | -0.201 |
| Dividends per Share |